AIs have become the principal choice for AET, with an increasing trend of combination with OFS.
← all excerpts
Adjuvant treatment strategy evolution and risk stratification for hormone receptor-positive, human epidermal growth factor receptor-2 negative early breast cancer in China.
1
—
—